Mendus to participate in multiple investor and industry conferences in September

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: H.C. Wainwright 25th Annual Global Investment Conference New York, USA, September 11-13, 2023 Mendus CEO Erik Manting will participate and present a Company Update at the conference: https://hcwevents.com/annualconference/ Pareto Securities' Annual Healthcare Conference Stockholm, Swe

Related Keywords

Stockholm ,Sweden ,Italy ,Netherlands ,Milan ,Lombardia ,United States ,New York ,Matfors ,Vasternorrland ,Erik Manting ,Corey Davis ,Mario Brkulj ,Hans Preusting ,Lotta Ferm ,Lifesci Advisors ,International Cancer Immunotherapy Conference ,Valency Communications ,Annual Global Investment ,Company Update ,Opening Ceremony ,Northx Innovation ,Nasdaq Stockholm ,Sci Advisors ,Iopharmaceutical Company ,Investment Conference ,Mendus Ab ,Industry Conferences ,Healthcare Conference ,Mmunotherapies ,Ancer Immunotherapy ,